Top Industry Leaders in the Needle Free Injection System Market
Latest Needle-Free Injection System Companies Update:
PharmaJet:
In November 2023, PharmaJet announced the first human clinical study to assess the U.S. Department of Defense DNA vaccine candidate against Venezuelan Equine Encephalitis delivered with its Precision Delivery Systems.
In October 2023, Daicel Group invested in PharmaJet, demonstrating confidence in the company's technology and market potential.PharmaJet also began a collaboration with Nigeria's National Primary Health Care Development Agency and a health-focused consortium to implement a study using its Tropis® ID for routine immunization, showcasing its commitment to global health initiatives.
Valeritas, Inc.:
Received FDA clearance in June 2023 for its V-Go™ Disposable Jet Injector for intradermal injection of Jeuveau® (prabotulinumtoxinA) for the treatment of glabellar lines (frown lines). This clearance marks a significant step forward for needle-free delivery of cosmetic injectables.
Antares Pharma:
Announced a strategic partnership with Trividia Therapeutics in December 2023 to develop and commercialize Trividia's novel intranasal naloxone product using Antares' proprietary Vibex® needle-free injection technology. This collaboration aims to improve access to life-saving naloxone for opioid overdose emergencies.
List of Needle-Free Injection System Key companies in the market
- Medical International Technology (MIT) (US)
- Antares Pharma. (US)
- Endo International (US)
- Ferring B.V. (Switzerland)
- Bioject Medical Technologies (US)
- NuGen Medical Devices (Canada)
- Portal Instruments (US)
- Enesi Pharma Limited (UK)
- Crossject (France)